Rentschler Biotechnologie GmbH, located in Laupheim, Germany, is a leading biopharmaceutical contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biopharmaceuticals and an experienced specialist in mammalian cell culture. The company’s clients include innovative biotech companies and major pharmaceutical companies around the world. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler’s high-quality standards. Rentschler Biotechnologie is a family-owned company employing approximately 700 people.
Full-Service Provider from Gene to Vial: Rentschler’s full-service offering includes all activities from bioprocess development through to current good manufacturing practice (CGMP) manufacturing, analytical testing, fill and finish, and all associated consulting activities in terms of project management and regulatory support.
Login to read the full PDF of the application note.